- Home
- IRMD vs GLAD Comparison
IRMD vs GLAD Comparison
Compare IRMD & GLAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRMD
- GLAD
- Stock Information
- Founded
- IRMD 1992
- GLAD 2001
- Country
- IRMD United States
- GLAD United States
- Employees
- IRMD N/A
- GLAD N/A
- Industry
- IRMD Medical/Dental Instruments
- GLAD Finance/Investors Services
- Sector
- IRMD Health Care
- GLAD Finance
- Exchange
- IRMD Nasdaq
- GLAD Nasdaq
- Market Cap
- IRMD 618.5M
- GLAD 554.2M
- IPO Year
- IRMD 2014
- GLAD N/A
- Fundamental
- Price
- IRMD $51.99
- GLAD $25.94
- Analyst Decision
- IRMD Strong Buy
- GLAD Hold
- Analyst Count
- IRMD 1
- GLAD 1
- Target Price
- IRMD $60.00
- GLAD $23.00
- AVG Volume (30 Days)
- IRMD 36.4K
- GLAD 126.9K
- Earning Date
- IRMD 10-31-2024
- GLAD 11-13-2024
- Dividend Yield
- IRMD 1.15%
- GLAD 7.63%
- EPS Growth
- IRMD 13.16
- GLAD 89.73
- EPS
- IRMD 1.46
- GLAD 4.34
- Revenue
- IRMD $71,305,130.00
- GLAD $96,621,000.00
- Revenue This Year
- IRMD $13.29
- GLAD $1.84
- Revenue Next Year
- IRMD $10.76
- GLAD N/A
- P/E Ratio
- IRMD $35.61
- GLAD $5.98
- Revenue Growth
- IRMD 13.23
- GLAD 11.79
- 52 Week Low
- IRMD $40.05
- GLAD $19.20
- 52 Week High
- IRMD $57.95
- GLAD $27.81
- Technical
- Relative Strength Index (RSI)
- IRMD 48.18
- GLAD 71.43
- Support Level
- IRMD $55.40
- GLAD $23.70
- Resistance Level
- IRMD $57.95
- GLAD $27.81
- Average True Range (ATR)
- IRMD 2.33
- GLAD 0.50
- MACD
- IRMD -0.04
- GLAD 0.13
- Stochastic Oscillator
- IRMD 46.26
- GLAD 54.50
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
About GLAD Gladstone Capital Corporation
Gladstone Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objectives are to, achieve and grow current income by investing in debt securities of established businesses that would provide stable earnings and cash flow to pay expenses, make principal and interest payments on its outstanding indebtedness and make distributions to stockholders that grow over time; and provide its stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses that can grow over time to permit it to sell its equity investments for capital gains.